ATS 2024 Final Program

Click on the session title to view the speakers

204

MONDAY • MAY 20

2:15 Vaccines to Address the Growing Threat of Antimicrobial Resistance 2:35 The Future of mRNA Vaccines for Infectious Diseases and Cancer Immunotherpay 2:55 Toward a Universal Flu Vaccine 3:15 The Future for Pediatric RSV Vaccination is Now

Tobacco and nicotine products are a threat to global health. Electronic nicotine delivery systems (e-cigarettes) and hea tobacco products threaten to expand the global tobacco epidemic. United States tobacco product policies and the way international tobacco product companies have an substantial impact on the global tobacco policy. This session aims tc provde an international perspective on tobacco product dependence and tobacco product control with a focus on low and mid-income countries. 2:15 Tobacco Dependence Treatment in Latin America 2:35 Tobacco and Vaping Product Control in Low and Middle Income Countries: Challenges and Successes 2:55 What Tobacco and Vaping Products are Used in the Developing World? 3:10 New Understandings of Vaping Product and Heated Tobacco Product Toxicity 3:25 Education and Counter-Marketing Campaigns in Latin America to Prevent Tobacco and Vaping Product Initiation and Increase Cessation of Use B90 IMPACT OF THE GUT-LUNG AXIS ON RESPIRATORY HEALTH ACROSS THE LIFESPAN Assemblies on Pediatrics; Clinical Problems 2:15 p.m. - 3:45 p.m. San Diego Convention Center Room 7A-B (Upper Level) Target Audience providers of lung health, trainees, basic researchers, translational researchers Objectives At the conclusion of this session, the participant will be able to: • describe new findings about mechanisms through which gut microbiota may impact respiratory health • define new strategies to manage the care of respiratory disorders through modulation of gut microbiota • apply multi-omic approaches to studying interactions between lung and gut health 3:35 General Discussion TRANSLATIONAL SCIENTIFIC SYMPOSIUM

3:35 Discussion 3:45 Discussion

This session and the International Conference are supported by an independent medical educational grant from Merck&Co., Inc.

All CMEsessions have been planned and implemented in accordancewith the AccreditationCriteria of theAccreditationCouncil for ContinuingMedical Education (ACCME ® ) andare freeof thecontrol of ineligiblecompanies (formerly commercial interests).

BEHAVIORAL • CLINICAL SCIENTIFIC SYMPOSIUM

B89 INTERNATIONAL PERSPECTIVE ON TOBACCO/VAPING PRODUCT/HEATED TOBACCO PRODUCT DEPENDENCE AND CONTROL Assemblies on Environmental, Occupational and Population Health; Behavioral and Health Services Research; Pediatrics; Thoracic Oncology 2:15 p.m. - 3:45 p.m. San Diego Convention Center Room 30A-B (Upper Level) Target Audience Physicians, health services researchers, tobacco researchers, epidemiologists, public policy advocates, public policy decision makers. Objectives At the conclusion of this session, the participant will be able to: • describe the successes and challenges facing tobacco control efforts in low and middle income countries, describe the types of tobacco products used, and describe populations at risk • describe the impacts on international tobacco control of the tobacco industry, the US Food and Drug Administration Center for Tobacco Products, and the World Health Organization Framework Convention on Tobacco Control (FCTC) • be able to articulate new understandings of the harms of electronic nicotine delivery systems and heated tobacco products

ATS 2024 Conference Program • San Diego, CA